Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
批准号:
10205054
负责人:
John P Thyfault
金额:
$46.6万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2023-06-30
关键词:
Acetyl Coenzyme AAcetylationAcuteAerobicAerobic ExerciseBile Acid Biosynthesis PathwayBile AcidsBiochemicalCholesterolChronicCitratesCitric Acid CycleClinicalCoenzyme ACytosolDataDevelopmentEpigenetic ProcessEventExcretory functionExerciseFatty LiverFatty acid glycerol estersFeedbackGene ExpressionGenesGeneticGenetic TranscriptionGluconeogenesisGoalsHepaticHigh Fat DietHistone AcetylationHomeostasisHumanHyperglycemiaInsulin ResistanceLinkLiverLiver MitochondriaLiver diseasesLongevityMediatingMetabolicMetabolic DiseasesMetabolic PathwayMitochondriaMitochondrial ProteinsModelingMolecularMusNon-Insulin-Dependent Diabetes MellitusNutrientObesityOutcomeOxidative StressOxygenPathologicPathologyPathway interactionsPatternPharmacologyPhenotypePhysical EndurancePhysical ExercisePhysical activityPlayPredispositionProtein AcetylationProteomicsRattusRoleRunningSterolsSucroseTestingTracerTrainingTranscriptional ActivationUp-Regulationbile acid metabolismcholest-4-en-3-onecholesterol controlendurance exerciseepigenetic regulationfeedinghuman subjectimprovedin vivolipid biosynthesismitochondrial metabolismmortality risknoveloverexpressionoxidationrespiratoryresponsesedentarytherapeutic targettooltraffickingtreadmill
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Low aerobic capacity (AC) is a powerful predictor of early mortality and risk for metabolic disease including excessive hepatic fat storage (steatosis). Conversely, high AC is clinically associated with protection against hepatic steatosis and a healthier, longer lifespan even in the face of obesity. We will utilize a rat model selectively bred for divergent intrinsic AC (high or low running capacity [HCR/LCR]) to unravel mechanisms by which AC impacts hepatic steatosis and metabolic pathologies. In a sedentary condition, HCR rats have a 40% higher intrinsic AC and are protected against high fat/sucrose (HFD)-induced hepatic steatosis and insulin resistance while LCR are highly susceptible. We have shown that differences in hepatic mitochondrial function (MitoFX: defined here as fat oxidation, and respiratory capacity) between the HCR and LCR play an important role in their protection or susceptibility for hepatic steatosis, respectively. New data suggests that hepatic metabolic flux through TCA cycle and gluconeogenesis are also elevated in the HCR over the LCR rat, but these pathways have yet to be examined in the context of protection against steatosis. In addition, novel preliminary data suggests HCR rats have elevated bile acid (BA) synthesis paired with increased fecal sterol and BA excretion compared to LCR. Exercise trained mice which also have elevated MitoFX and are protected from steatosis show evidence of a similar upregulation of BA synthesis and excretion. We will test the hypothesis that increases in hepatic BA synthesis and fecal excretion is critical to the high AC and chronic exercise phenotype(s) and contributes to hepatic MitoFx, metabolic flux, and protection of steatosis by: 1) Pulling acetyl-CoA out of the mitochondria (minimizing feedback inhibition and mitochondrial protein acetylation) and 2) diverting acetyl-CoA away from accumulation and de-novo-lipogenesis (DNL) and towards BA synthesis and subsequent fecal loss via a “siphoning mechanism”. We will test these mechanisms utilizing pharmacological and molecular tools to modulate CYP7a1 activity and BA synthesis combined with in-vivo metabolic tracers in HCR/LCR rats and exercise vs. sedentary mice. Additionally, HCR livers display greater metabolic and transcriptional adaptability in response to high-fat diet (HFD) feeding than LCR. Our preliminary data suggests that enhanced transcriptional adaptability in the HCR livers is caused by increases in the acetylation of histones (H3K9ac and H3K27ac) that coordinate expression of genes involved in mitochondrial metabolism and specifically for BA synthesis. Thus, we posit that high AC and exercise induced increases in metabolic flux and enhanced BA synthesis likely increase acetyl CoA flux out of the mitochondria and into the cytosol where it can serve as a substrate for histone acetylation. This proposal will also test the hypothesis that livers from HCR rats and from exercised mice can transcriptionally adapt to high fat diets and avoid steatosis through a relationship linking hepatic MitoFX, BA synthesis and excretion, and epigenetic mechanisms (histone acetylation).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
-
批准号:10725916
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2022
-
负责人:John P Thyfault
-
依托单位:
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
-
批准号:10598012
-
项目类别:
-
资助金额:$232.0万
-
财政年份:2022
-
负责人:John P Thyfault
-
依托单位:
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
-
批准号:10799329
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2022
-
负责人:John P Thyfault
-
依托单位:
Translating Obesity, Metabolic Dysfunction and Comorbid Disease States
-
批准号:10411630
-
项目类别:
-
资助金额:$10.55万
-
财政年份:2022
-
负责人:John P Thyfault
-
依托单位:
Translating Obesity, Metabolic Dysfunction and Comorbid Disease States
-
批准号:10623307
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2022
-
负责人:John P Thyfault
-
依托单位:
Divergence in Aerobic Capacity Drives Liver and Brain Health
-
批准号:10286535
-
项目类别:
-
资助金额:$37.76万
-
财政年份:2019
-
负责人:John P Thyfault
-
依托单位:
Aerobic Fitness, Mitochondrial Function, and Fatty Liver Disease.
-
批准号:10442514
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2019
-
负责人:John P Thyfault
-
依托单位:
Skeletal muscle mitochondrial abnormalities in Alzheimer's Disease
-
批准号:9474088
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2017
-
负责人:John P Thyfault
-
依托单位:
Skeletal muscle mitochondrial abnormalities in Alzheimer's Disease
-
批准号:9322823
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2017
-
负责人:John P Thyfault
-
依托单位:
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
-
批准号:9891404
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:John P Thyfault
-
依托单位:
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
-
批准号:10292445
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:John P Thyfault
-
依托单位:
Mitochondrial mitophagy in the development and treatment of NAFLD
-
批准号:8967101
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:John P Thyfault
-
依托单位:
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
-
批准号:10516037
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:John P Thyfault
-
依托单位:
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
-
批准号:8639555
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2011
-
负责人:John P Thyfault
-
依托单位:
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
-
批准号:8304926
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2011
-
负责人:John P Thyfault
-
依托单位:
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
-
批准号:8828673
-
项目类别:
-
资助金额:$28.31万
-
财政年份:2011
-
负责人:John P Thyfault
-
依托单位:
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
-
批准号:8104879
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2011
-
负责人:John P Thyfault
-
依托单位:
Aerobic fitness, mitochondrial dysfunction, and fatty liver disease
-
批准号:8446392
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2011
-
负责人:John P Thyfault
-
依托单位:
海外基金